BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer

Clinical trial NCT00708214 · COMPLETED

Trial details

NCT number: NCT00708214
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2007-01-01
Primary completion: 2010-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.